icad Inc (ICAD)
1.48
+0.04
(+2.78%)
USD |
NASDAQ |
May 09, 16:00
1.46
-0.02
(-1.35%)
After-Hours: 20:00
icad SG&A Expense (Quarterly): 3.724M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.724M |
September 30, 2023 | 3.537M |
June 30, 2023 | 4.944M |
March 31, 2023 | 5.719M |
December 31, 2022 | 5.297M |
September 30, 2022 | 5.41M |
June 30, 2022 | 6.177M |
March 31, 2022 | 6.496M |
December 31, 2021 | 7.341M |
September 30, 2021 | 6.544M |
June 30, 2021 | 6.081M |
March 31, 2021 | 5.575M |
December 31, 2020 | 6.735M |
September 30, 2020 | 4.813M |
June 30, 2020 | 4.741M |
March 31, 2020 | 6.14M |
December 31, 2019 | 6.52M |
September 30, 2019 | 5.46M |
June 30, 2019 | 4.978M |
March 31, 2019 | 4.119M |
December 31, 2018 | 6.119M |
September 30, 2018 | 3.878M |
June 30, 2018 | 3.589M |
March 31, 2018 | 4.224M |
December 31, 2017 | 4.141M |
Date | Value |
---|---|
September 30, 2017 | 4.524M |
June 30, 2017 | 4.779M |
March 31, 2017 | 4.936M |
December 31, 2016 | 4.889M |
September 30, 2016 | 4.105M |
June 30, 2016 | 4.738M |
March 31, 2016 | 4.122M |
December 31, 2015 | 4.839M |
September 30, 2015 | 4.815M |
June 30, 2015 | 5.495M |
March 31, 2015 | 6.043M |
December 31, 2014 | 5.764M |
September 30, 2014 | 5.73M |
June 30, 2014 | 4.737M |
March 31, 2014 | 4.281M |
December 31, 2013 | 4.823M |
September 30, 2013 | 4.051M |
June 30, 2013 | 3.939M |
March 31, 2013 | 4.11M |
December 31, 2012 | 3.996M |
September 30, 2012 | 4.615M |
June 30, 2012 | 4.091M |
March 31, 2012 | 4.241M |
December 31, 2011 | 4.539M |
September 30, 2011 | 5.255M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
3.537M
Minimum
Sep 2023
7.341M
Maximum
Dec 2021
5.591M
Average
5.575M
Median
Mar 2021
SG&A Expense (Quarterly) Benchmarks
ClearPoint Neuro Inc | 6.067M |
Perspective Therapeutics Inc | 1.694M |
Xtant Medical Holdings Inc | 20.45M |
Asensus Surgical Inc | 7.773M |
Catheter Precision Inc | 2.729M |